Advertisement

How Feds Decide On Remdesivir Shipments To States Remains Mysterious

The experimental antiviral drug remdesivir shortened hospital stays for seriously ill COVID-19 patients in a federally funded study. But there's not enough of the medicine to go around. (Pool/AFP via Getty Images)
The experimental antiviral drug remdesivir shortened hospital stays for seriously ill COVID-19 patients in a federally funded study. But there's not enough of the medicine to go around. (Pool/AFP via Getty Images)

Related:

Advertisement

More from WBUR

Listen Live
Close